T h e short consensus/complement repeat (SCR) domain (also known as the complement control protein domain) is the most abundant domain type in the complement system. Crystal and N M R structures for proteins that contain single and multiple SCR domains have now been published. These contain inter-SCR linkers of between three and eight residues, and the structures show much variability in inter-SCR orientations. X-ray and neutron scattering, combined with analytical ultracentrifugation and constrained modelling based on known subunit structures will yield a medium-resolution structure for the protein of interest. T h e fewer parameters that are associated with the structure of interest, the more defined the structure of interest becomes. These solution studies have been applied to several SCRcontaining proteins in the complement system, most notably Factor H with 20 SCR domains, a complement receptor type 2 fragment with two SCR domains, and rat complement receptorrelated protein (Crry) which contains five SCR domains. T h e results show great conformational variability in the inter-SCR orientation, and these will be reviewed. Even though the rotational orientation cannot be modelled, it is nonetheless
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The complement system
T h e components of the complement system provide a major non-adaptive immune defence mechanism for the host [l] . These are activated in response to the challenge of foreign material in plasma, with C3 being the central complement protein. Complement activation proceeds through a series of limited proteolytic steps in one of three pathways : the alternative, the classical and the lectin pathway. In the alternative pathway, the deposition of C3b on foreign surfaces is amplified by interactions with the Bb fragment which is formed b y the action of the serine proteases Factor B and Factor D , and controlled by the cofactor Factor H (FH) and the serine protease Factor I . T h e C3b-Bb complex converts C3 into C3b; C3b is an essential component of C5-cleaving enzymes. One of the breakdown products of C3b is C3d, which remains attached to the foreign antigen, and this is bound by complement receptor type 2 (CR2, CD21). T h e cross-linking of CR2 to the B-cell receptor through a C3d-antigen complex amplifies a signal transduction cascade through a co-activation complex with CD19 and CD81 [2].
In addition, CR2 is the receptor for CD23 and the Epstein-Barr virus. Proteins such as F H are central to the activation of the complement pathways, while complement receptors such as CR2 provide a key interface between the innate and adaptive immune systems. Occurrence of short consensuslcomplement repeat (SCR) domains in complement proteins Many complement proteins are multidomain proteins [3] . F H and CR2 are almost entirely composed of SCR domains, also known as complement control (or SUSHI) protein domains. This is the most common domain type in complement. Interestingly, even though the immunoglobulin superfamily, with its characteristic seven-or ninestranded &sheet sandwich structure, is the most abundant fold in multidomain proteins, this domain type is absent from the complement proteins. FH contains 20 SCRs, while CR2 contains 15 or 16 SCRs, and other complement proteins such as human C l r , Cls, C4b-binding protein (C4BP), decay-acceleration factor (DAF; CDSS), membrane cofactor protein (MCP; CD46), Factor B and rodent Crry also contain SCRs [ l ] ( Table 1) . SCRs also occur in noncomplement proteins, e.g. the vaccinia viral coat protein (VCP) is a mimic of complement activity, while p2-glycoprotein I is a membrane-bound anticoagulant that is associated with antiphospholipid syndrome.
SCRs are generally considered to be functionally active in pairs. In FH, three sets of SCRs bind to various parts of C3. Domain deletion studies showed that F H SCR-7 and SCR-20 have heparin-binding properties and that SCR-13 may also bind heparin [4] . T h e SCR-1 and SCR-2 domains of C4BP bind to C4b and heparin [S] , while C3d binds to the SCR-1 and SCR-2 domains of CR2 [6] . SCRs are therefore capable of binding to carbohydrate and/or protein ligands. Since two SCR domains frequently mediate these interactions, the structures of both the individual SCRs and the linker region between them are equally important for assessing function.
Structure of an SCR domain and SCR pairs
A typical SCR fold contains 61 residues, four of which are cysteine residues. Its six-stranded 8-sheet structure was first identified by prediction methods and Fourier transform IR spectroscopy [7] . The earliest solution scattering studies of F H and C4BP showed that the SCR domains formed extended structures in solution [8,9]. T h e earliest electron microscopy studies performed in ZIUCUO indicated SCR arrangements that were either convoluted and folded-back (FH and CR2) or extended multi-armed spider-like (C4BP) [10-121. The first molecular structures of F H SCRs that were determined by N M R revealed the typical elongated six-stranded P-sheet structure with a Cys-Cys bridge at each of the two ends of this structure [13] .
Crystal structures have recently been determined for SCR pairs in MCP, CR2, and D A F [1+17], four SCRs in VCP [18] , and five SCRs in P2-glycoprotein I [19, 20] . T h e crystal structures are of better quality than the N M R structures. One important result from crystallography is the high structural conservation of the SCR P-sheet structure, where six P-strands occur as three distinct pairs of anti-parallel P-strands in SCRs, and sometimes a fourth pair of P-strands is present. Another important result is the high conformational variability of the interdomain linker that connects two SCRs even when the linkers are as short as three or four residues (Figure la) . T h e linker is either completely extended (p2-glycoprotein I) or folded-back (CR2), and can be rotationally reorientated in a wide range of conformers (VCP, MCP, FH). These orientations are determined both by the linker structure itself and by inter-SCR contacts made between adjacent surface loops. In comparison, the nine-stranded V-type or seven-stranded C2-type immunoglobulin folds are similar in length to a SCR domain (Figure lb) , and pairs of these can also exist in a range of interdomain orientations.
Solution structure of 20 SCRs in FH
A new method of highly constrained solution scattering and ultracentrifugation modelling has been developed. Traditionally, both scattering and ultracentrifugation are low-resolution structural methods that provide data on overall macromolecular shapes. It was then established that the experimental data can be modelled using known molecular structures [21, 22] . Consequently, for a multidomain protein, if the modelling analysis is constrained by the use of known domain structures as rigid bodies, and the domains are connected by flexible linkers which can be modelled using molecular dynamics, a large number of full struc- 
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tures can be generated. These are compared with the data in a trial-and-error procedure. After removal of the poor-fit models, a family of related medium-resolution best-fit structures is obtained. In these, the approximate positions of individual amino acids can potentially be determined with a precision that is comparable to that of homology or comparative modelling.
T o determine the arrangement of the 20 SCRs in FH, X-ray and neutron scattering and analytical ultracentrifugation data were obtained [23] . T h e X-ray and neutron radii of gyration (R,) of F H was 11.1-11.3 nm, and the sedimentation coefficient was 5.3k0.1 S. The X-ray and neutron data showed that the maximum length of F H was 40 nm. If all the SCRs in FH were fully extended in conformation, FH would be 73 nm long. This difference shows that the 20 SCRs in F H are on average folded-back upon themselves in solution.
The scattering data were compared with modelling results based on a comparison with over 16000 randomized linked arrangements for the 20 SCRs. The best-fits showed that folded-back molecular structures for FH gave good agreements with the scattering data (Figure 2b) . One explanation of this folding-back is the existence of four long linkers, 6-8 residues long, between SCR-10 and SCR-14 at the centre of FH, and one more between SCR-18 and SCR-19 (Table 1) . These can exist in extended or folded-back conformation as seen in CR2 [15, 24] . T h e position of the SCR-10-14 cluster of linkers coincided with the largest amount of interspecies variability in F H structures. Flexibility in these long linkers would cause the FH structure to adopt multiple conformations, and, on average, FH would not be extended.
Another explanation is the presence of proline residues in some F H linkers which would impose semi-rigid kinks in the F H structure. These folded-back structures may correspond to conformational flexibility that enables the multiple F H binding sites for C3 and heparin to act synergistically with each other. T h e F H structures enabled the interpretation of the consequence of 12 missense mutations that are associated with haemolytic anaemic syndrome, a disease involved with renal disorders and kidney failure [ 2 5 ] . T e n of these occur in SCR-19 and SCR-20, with one in SCR-19 and nine at eight positions in SCR-20. T h e homology model for SCR-20 showed that most of the mutations are clustered close together and are immediately adjacent to conserved basic residues. This cluster could be correlated with a predicted heparin binding-site in SCR-20, for which a model of the heparin-SCR-20 complex could be constructed. T h e interdomain orientation between SCR-19 and SCR-20 is relevant for assessing the single mutation in SCR-19. T h e range of this variation is restricted as the linker is only three residues long. T h e SCR-19 mutation is close to the cluster of mutations in SCR-20 in the best-fit models, thus it is possible that SCR-19 may contribute towards the formation of a two-SCR heparin binding site in FH. While no information could be obtained on the binding of C3d to SCR-20 by this approach, the structural modelling has been informative on the likely biological function of SCR-19 and SCR-20.
Solution structures of SCRs in CR2 and Crry
Since the FH study suggested that the inter-SCR linker length is crucial for the conformation between two SCRs, and since the first two SCRs in CR2 are joined by a long eight-residue linker (Table l) , this long linker in CR2 SCR-1/2 merited further study. T h e recent crystal structure of the C3d-CR2 SCR-1/2 complex showed that the first two SCRs of CR2 were folded-back upon each other, with only SCR-2 making contact with C3d [15] . T h e crystal structure of free CR2 SCR-1/2 also showed a similar folded-back structure, with minor rearrangement of the inter-SCR orientation [17] . T h e solution structure for the C3d-CR2 SCR-1/2 complex was investigated by analytical ultracentrifugation. T h e sedimentation coefficient of free CR2 SCR-1/2 was 1.36kO.2 S, and this is seen to be monomeric, for free C3d, the sedimentation coefficient was 3.43 f 0 . 4 S, and for the complex it was 3.50f0.6 S [24, 26] . In the modelling, the reorientation of CR2 SCR-1/2 0 2002 Biochemical Society from the arrangement observed in its co-crystal structure into an extended conformation accounted for this sedimentation coefficient (Figure 2c) . Note that the rotational twist between the long axes of SCR-1 and SCR-2 cannot be determined by this approach; only the opening-up of the folded-back structure. Modelling based on the crystal structure of C3d agreed with its sedimentation coefficient. T h e modelling of the C3d-CR2 SCR-l/2 complex showed that the two SCR domains were again unfolded in solution. As the folded-back SCR-1/2 domain seen in the crystal structure of the C3d-CR2 SCR-1/2 complex is not apparently observed in solution, it is concluded that long inter-SCR linkers can be observed in radically different conformations.
Since the FH modelling suggested that the solution structures of SCRs joined by short linkers would be extended, the availability of rat Crry permitted this hypothesis to be investigated. T h e four linkers in Crry are four or five residues long (Table 1) (Figure 2a) . Accordingly rat Crry is conformationally extended in solution as predicted, although a small degree of bending in the Crry model would lead to the observed shortening of 1 nm.
Conclusions
SCRs are widespread in the complement proteins, and the solution conformation between adjacent SCR pairs is central to an understanding of the molecular mechanism of complement activation. Scattering curve modelling, based on known domain structures as rigid constraints, provides useful information on the solution structures of SCR proteins [21, 22] . If the inter-SCR linkers are as long as eight residues, the studies with FH and CR2 show that significantly folded-back or extended structures can be formed [15, 23, 24] . If the inter-SCR linkers are four or five residues in length, only a modest degree of bending will result. Overall, our work shows that multi-SCR proteins are best viewed as the assembly of rigid singledomain structures that may or may not be joined by flexible linker conformations to their neighbours. If this interpretation is correct, it means that crystal structures may correspond only to a frozen snapshot of one allowed conformation, when in fact more flexibility may exist between SCR domains in solution. Solution studies will continue to be of great relevance for the elucidation of structure-function relationships in the SCR proteins.
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